We hear about cancer research all the time. We participate in walks or runs to help raise money for cancer research, but few of us outside of oncology departments or research labs do true research into what can actually be done to move the process along.
That’s because we are layman, not doctors, right? Tech guru Eric Lefkofsky is proving that thought to be incredibly wrong. Several years ago his wife was unexpectedly diagnosed with breast cancer. Being a man of action and research, he set about to study exactly what the treatment process was. What he found displeased him a great deal. Everywhere he looked he saw the volumes of data that were being collected. However, he found there was no one harnessing that data into a streamlined system so others could utilize it in the cancer treatment process. It was as if data was piling up in a stock room, but no one had the keys and learn more about Eric.
After finding this disconnect, Eric rallied his partners in the tech community to found Tempus. Tempus put the power of the tech community to work to revolutionize the way cancer was treated by putting data first when it came to cancer care and Eric’s lacrosse camp.
First, Tempus dealt with the fact that the “data” that was being collected was over physician’s notes. These notes were captured and stores, but they were basically useless. A doctor in Seattle couldn’t access a physician’s notes in New York and even if or when they could, they were simply notes on an individual patient that may not translate into another patient’s cancer treatment. Tempus overcame that by developing a platform that could read the notes and turn them into structured data that can be directly applied to cancer treatment to anyone that accessed the notes and Eric’s website.
From there, Tempus has to overcome the hurdle of needing to collect molecular data to pair with physician’s data. This is done through Human Genome Sequencing. The Human Genome Sequencing process used to be something that was typically out of reach, costing millions and millions of dollars. However, as research by Tempus and other forward-thinking companies pushed back, the process now costs just a few thousand dollars, with costs expecting to continue to drop and more information click here.